Whitehawk Therapeutics (WHWK) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $2.89, -4.93% vs the prior close of $3.04.
- Volume 273.98K shares, 0.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
WHWK slides 4.9% to $2.89, a 6-month low. Closed at $2.89, -4.93% vs the prior close of $3.04. Day range $2.87–$3.03, opened at $3.03.
WHWK daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — WHWK slides 4.9% to $2.89, a 6-month low
- Closed at $2.89, -4.93% vs the prior close of $3.04. Day range $2.87–$3.03, opened at $3.03.
- Volume was 273.98K shares, 0.8x its 50-day average of 344.55K.
- Price is -30.4% vs its 50-day average ($4.15) and -24.1% vs its 200-day average ($3.81).
- 52-week range $1.97–$5.49; today's close sits at 26% of that range, 47.4% below the 52-week high.
Oct 15, 2026 — WHWK rises 2.4% to $3.04
- Closed at $3.04, +2.36% vs the prior close of $2.97. Day range $2.98–$3.08, opened at $2.98.
- Volume was 337.40K shares, 1.0x its 50-day average of 349.79K.
- Price is -27.4% vs its 50-day average ($4.19) and -20.1% vs its 200-day average ($3.80).
- 52-week range $1.97–$5.49; today's close sits at 30% of that range, 44.7% below the 52-week high.
Oct 14, 2026 — WHWK dips 1.7% to $2.97, a 6-month low, 3 down days in a row
- Closed at $2.97, -1.66% vs the prior close of $3.02. Day range $2.94–$3.11, opened at $3.05.
- Volume was 510.10K shares, 1.5x its 50-day average of 349.01K.
- Price is -29.4% vs its 50-day average ($4.21) and -21.9% vs its 200-day average ($3.80).
- 52-week range $1.87–$5.49; today's close sits at 30% of that range, 46.0% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — WHWK slides 10.7% to $3.02, a 6-month low
- Closed at $3.02, -10.65% vs the prior close of $3.38. Day range $3.00–$3.37, opened at $3.37.
- Volume was 461.20K shares, 1.3x its 50-day average of 346.37K.
- Price is -28.6% vs its 50-day average ($4.23) and -20.6% vs its 200-day average ($3.80).
- 52-week range $1.87–$5.49; today's close sits at 32% of that range, 45.0% below the 52-week high.
Oct 12, 2026 — WHWK slides 4.0% to $3.38, a 6-month low
- Closed at $3.38, -3.98% vs the prior close of $3.52. Day range $3.36–$3.57, opened at $3.52.
- Volume was 222.10K shares, 0.6x its 50-day average of 348.12K.
- Price is -20.5% vs its 50-day average ($4.25) and -11.0% vs its 200-day average ($3.80).
- 52-week range $1.87–$5.49; today's close sits at 42% of that range, 38.5% below the 52-week high.
Oct 9, 2026 — WHWK rises 1.4% to $3.52
- Closed at $3.52, +1.44% vs the prior close of $3.47. Day range $3.40–$3.54, opened at $3.47.
- Volume was 319.80K shares, 0.9x its 50-day average of 347.00K.
- Price is -17.3% vs its 50-day average ($4.26) and -7.3% vs its 200-day average ($3.80).
- 52-week range $1.87–$5.49; today's close sits at 46% of that range, 35.9% below the 52-week high.
Oct 8, 2026 — WHWK rises 1.8% to $3.47
- Closed at $3.47, +1.76% vs the prior close of $3.41. Day range $3.33–$3.52, opened at $3.37.
- Volume was 248.60K shares, 0.7x its 50-day average of 356.40K.
- Price is -18.6% vs its 50-day average ($4.27) and -8.5% vs its 200-day average ($3.79).
- 52-week range $1.87–$5.49; today's close sits at 44% of that range, 36.9% below the 52-week high.
Oct 7, 2026 — WHWK slides 5.5% to $3.41, a 3-month low, 5 down days in a row
- Closed at $3.41, -5.54% vs the prior close of $3.61. Day range $3.35–$3.60, opened at $3.55.
- Volume was 435.70K shares, 1.2x its 50-day average of 358.30K.
- Price is -20.1% vs its 50-day average ($4.27) and -9.9% vs its 200-day average ($3.79).
- 52-week range $1.87–$5.49; today's close sits at 42% of that range, 37.9% below the 52-week high.
- That makes 5 straight losses.
Oct 6, 2026 — WHWK dips 2.4% to $3.61, a 3-month low, 4 down days in a row
- Closed at $3.61, -2.43% vs the prior close of $3.70. Day range $3.55–$3.72, opened at $3.72.
- Volume was 468.10K shares, 1.3x its 50-day average of 363.69K.
- Price is -15.5% vs its 50-day average ($4.27) and -4.5% vs its 200-day average ($3.78).
- 52-week range $1.87–$5.49; today's close sits at 48% of that range, 34.3% below the 52-week high.
- That makes 4 straight losses.
Oct 5, 2026 — WHWK ends flat (+0.0%) to $3.70, 3 down days in a row
- Closed at $3.70, +0.00% vs the prior close of $3.70. Day range $3.61–$3.75, opened at $3.73.
- Volume was 289.10K shares, 0.8x its 50-day average of 366.07K.
- Price is -13.5% vs its 50-day average ($4.28) and -2.0% vs its 200-day average ($3.77).
- 52-week range $1.87–$5.49; today's close sits at 50% of that range, 32.7% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — WHWK dips 1.6% to $3.70, a 1-month low
- Closed at $3.70, -1.60% vs the prior close of $3.76. Day range $3.66–$3.81, opened at $3.81.
- Volume was 431.80K shares, 1.2x its 50-day average of 366.99K.
- Price is -13.5% vs its 50-day average ($4.28) and -1.8% vs its 200-day average ($3.77).
- 52-week range $1.86–$5.49; today's close sits at 51% of that range, 32.7% below the 52-week high.
WHWK latest news & SEC filings
Every SEC filing by or about WHWK in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 18, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 18, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 18, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 18, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 18, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 15, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $0 (prior year $0)
- Net income: -$16.64M (prior year -$52.62M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.20 (prior year -$0.76) (loss narrowed vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade WHWK
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Mar 12, 2026, Nov 6, 2025. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.59% (largest 10.7%).
- Liquidity: about 308.53K shares (≈$891.65K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $2.89 vs a range of $1.97–$5.49 (26% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Scott M. Giacobello sold 141,600 shares on Apr 16, 2026.
- Latest filings: 8-K Sep 10, 2026; 10-Q Aug 6, 2026; 8-K Aug 6, 2026.
- Share count: 57.01M shares outstanding (Aug 3, 2026), +21.0% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
WHWK market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 3.03 | 3.03 | 2.87 | 2.89 | 273.98K |
| Oct 15, 2026 | 2.98 | 3.08 | 2.98 | 3.04 | 337.40K |
| Oct 14, 2026 | 3.05 | 3.11 | 2.94 | 2.97 | 510.10K |
| Oct 13, 2026 | 3.37 | 3.37 | 3.00 | 3.02 | 461.20K |
| Oct 12, 2026 | 3.52 | 3.57 | 3.36 | 3.38 | 222.10K |
| Oct 9, 2026 | 3.47 | 3.54 | 3.40 | 3.52 | 319.80K |
| Oct 8, 2026 | 3.37 | 3.52 | 3.33 | 3.47 | 248.60K |
| Oct 7, 2026 | 3.55 | 3.60 | 3.35 | 3.41 | 435.70K |
| Oct 6, 2026 | 3.72 | 3.72 | 3.55 | 3.61 | 468.10K |
| Oct 5, 2026 | 3.73 | 3.75 | 3.61 | 3.70 | 289.10K |
| Oct 2, 2026 | 3.81 | 3.81 | 3.66 | 3.70 | 431.80K |
| Oct 1, 2026 | 3.95 | 3.95 | 3.75 | 3.76 | 207.40K |
| Sep 30, 2026 | 3.76 | 3.84 | 3.68 | 3.76 | 265.60K |
| Sep 29, 2026 | 3.76 | 3.79 | 3.68 | 3.73 | 221.90K |
| Sep 28, 2026 | 3.74 | 3.80 | 3.68 | 3.76 | 277.90K |
| Sep 25, 2026 | 3.85 | 3.89 | 3.74 | 3.74 | 167.00K |
| Sep 24, 2026 | 3.81 | 3.90 | 3.75 | 3.86 | 245.80K |
| Sep 23, 2026 | 4.02 | 4.07 | 3.82 | 3.82 | 248.50K |
| Sep 22, 2026 | 4.08 | 4.17 | 4.01 | 4.04 | 149.00K |
| Sep 21, 2026 | 4.19 | 4.20 | 4.00 | 4.04 | 389.60K |
About Whitehawk Therapeutics
Whitehawk Therapeutics (WHWK) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in MORRISTOWN, NJ. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1422142.
WHWK board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Behzad Aghazadeh | See remarks | Jun 15, 2026 |
| Capital Advisors Llc Avoro | See remarks | Jun 15, 2026 |
| Ventures Llc Avoro | See remarks | Jun 15, 2026 |
| Caley Castelein | Director | Jun 15, 2026 |
| Anupam Dalal | Director | Jul 30, 2026 |
| Neil Desai | Director | Jun 15, 2026 |
| Mohammad Hirmand | Director | Jun 15, 2026 |
| Vijay K Iyengar | Director | Sep 11, 2026 |
| David James Lennon | CHIEF EXECUTIVE OFFICER | Sep 18, 2026 |
| Richard E Maroun | Director | Jun 15, 2026 |
| Emma Reeve | Director | Jun 15, 2026 |
| Baiteng Zhao | Director | Jun 15, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Bryan Ball | See remarks | Sep 18, 2026 |
| David Dornan | Chief Scientific Officer | Sep 18, 2026 |
| Margaret Dugan | Chief Medical Officer | Sep 18, 2026 |
| Scott M. Giacobello | CHIEF FINANCIAL OFFICER | Sep 18, 2026 |
| David James Lennon | CHIEF EXECUTIVE OFFICER | Sep 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Apr 16, 2026 | Scott M. Giacobello | Sale | 141,600 | $4.13 |
| Apr 16, 2026 | Scott M. Giacobello | Sale | 141,600 | $4.13 |
| Apr 16, 2026 | Scott M. Giacobello | Sale | 141,600 | $4.13 |
| Apr 16, 2026 | Scott M. Giacobello | Sale | 141,600 | $4.13 |
| Apr 15, 2026 | Scott M. Giacobello | Sale | 77,000 | $3.86 |
| Apr 15, 2026 | Scott M. Giacobello | Sale | 77,000 | $3.86 |
| Apr 15, 2026 | Scott M. Giacobello | Sale | 77,000 | $3.86 |
| Apr 15, 2026 | Scott M. Giacobello | Sale | 77,000 | $3.86 |
| Apr 14, 2026 | Bryan Ball | Sale | 92,460 | $3.64 |
| Apr 14, 2026 | Bryan Ball | Sale | 92,460 | $3.64 |
| Apr 14, 2026 | Bryan Ball | Sale | 92,460 | $3.64 |
| Apr 14, 2026 | Bryan Ball | Sale | 92,460 | $3.64 |
| Apr 13, 2026 | Bryan Ball | Sale | 26,389 | $3.46 |
| Apr 13, 2026 | Bryan Ball | Sale | 26,389 | $3.46 |
| Apr 13, 2026 | Bryan Ball | Sale | 26,389 | $3.46 |
WHWK financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $7.14M | $-20.60M | -0.33 | $-97.43M |
| Dec 31, 2024 | $25.98M | $-63.69M | -2.36 | $-59.55M |
| Dec 31, 2023 | $24.35M | $-65.77M | -2.44 | $-59.66M |
| Dec 31, 2022 | $15.22M | $-60.51M | -2.69 | $-49.64M |
| Dec 31, 2021 | $14.00M | $-110.09M | -12.41 | $-22.42M |
Latest balance sheet: total assets $193.99M, total liabilities $11.07M, cash $85.23M (as of Jun 30, 2026).
WHWK earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $4.70 |
| May 7, 2026 | 8-K Item 2.02 (results) | $3.94 |
| Mar 12, 2026 | 8-K Item 2.02 (results) | $3.90 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $2.10 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $1.72 |
| May 8, 2025 | 8-K Item 2.02 (results) | $1.64 |
| Mar 18, 2025 | 8-K Item 2.02 (results) | $2.05 |
| Nov 6, 2024 | 8-K Item 2.02 (results) | $2.12 |
| Aug 7, 2024 | 8-K Item 2.02 (results) | — |
| May 8, 2024 | 8-K Item 2.02 (results) | — |
| Mar 13, 2024 | 8-K Item 2.02 (results) | — |
| Nov 8, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on WHWK
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.